The Potential of Antimicrobial Peptides as Biocides

被引：133

作者：

Laverty, Garry ^{[1
]}

Gorman, Sean P. ^{[2
]}

Gilmore, Brendan F. ^{[2
]}

机构：

[1] Ward Biotech Ltd, Glasdrummann, Milltown, Monaghan, Ireland

[2] Queens Univ Belfast, Sch Pharm, Biomat Res Grp, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2011年 / 12卷 / 10期

关键词：

antimicrobial; peptides; biocides; IN-VITRO ACTIVITY; RESISTANT PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE PEPTIDES; ESCHERICHIA-COLI; CANDIDA-ALBICANS; ANTIBACTERIAL PEPTIDES; POLYMYXIN-B; FATTY-ACIDS; MACROMOLECULAR-SYNTHESIS; STAPHYLOCOCCUS-AUREUS;

D O I：

10.3390/ijms12106566

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Antimicrobial peptides constitute a diverse class of naturally occurring antimicrobial molecules which have activity against a wide range of pathogenic microorganisms. Antimicrobial peptides are exciting leads in the development of novel biocidal agents at a time when classical antibiotics are under intense pressure from emerging resistance, and the global industry in antibiotic research and development stagnates. This review will examine the potential of antimicrobial peptides, both natural and synthetic, as novel biocidal agents in the battle against multi-drug resistant pathogen infections.

引用

页码：6566 / 6596

页数：31

共 226 条

[1] The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].

Agerberth, B ;

Charo, J ;

Werr, J ;

Olsson, B ;

Idali, F ;

Lindbom, L ;

Kiessling, R ;

Jörnvall, H ;

Wigzell, H ;

Gudmundsson, GH .

BLOOD, 2000, 96 (09) :3086-3093

[2] AEROSPORIN, AN ANTIBIOTIC PRODUCED BY BACILLUS-AEROSPORUS GREER [J].

AINSWORTH, GC ;

BROWN, AM ;

BROWNLEE, G .

NATURE, 1947, 160 (4060) :263-263

[3] Peptide antibiotics: An alternative and effective antimicrobial strategy to circumvent fungal infections [J].

Ajesh, K. ;

Sreejith, K. .

PEPTIDES, 2009, 30 (05) :999-1006

[4] Daptomycin, a new drug class for the treatment of gram-positive infections [J].

Alder, JD .

DRUGS OF TODAY, 2005, 41 (02) :81-90

[5]

Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO

[6]

2-D

[7] THE EFFECT OF CULTURAL CONDITIONS ON THE ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI AND STREPTOCOCCI [J].

ANDREW, JH ;

WALE, MCJ ;

WALE, LJ ;

GREENWOOD, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (02) :213-221

[8] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].

Arbeit, RD ;

Maki, D ;

Tally, FP ;

Campanaro, E ;

Eisenstein, BI .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681

[9] A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid [J].

Avrahami, D ;

Shai, Y .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12277-12285

[10] Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: A plausible mode of action [J].

Avrahami, D ;

Shai, Y .

BIOCHEMISTRY, 2003, 42 (50) :14946-14956

← 1 2 3 4 5 6 7 8 9 10 →